MedPath

Introduction to the market of an innovative method of rehabilitation through verification of the effectiveness of the most modern diagnostic and therapeutic methods in patients with cerebral palsy

Not Applicable
Recruiting
Conditions
cerebral palsy
Physical Medicine / Rehabilitation - Physiotherapy
Registration Number
ACTRN12618001238268
Lead Sponsor
P.H.U. Technomex Sp. z o.o.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

• confirmed cerebral palsy
• a minimum child height of 150 cm,
• the ability to walk or walk alone with help (the ability to walk at least 4-5 meters alone, with a balcony, with crutches or holding one hand by an accompanying person,
• no contraindications to carry out gait training on the part of the musculoskeletal system or other systems,
• a period of at least 6 months from the administration of botulinum toxin and the lack of surgical procedures performed within the lower limbs within the last 2 years,
• no dislocation or subluxation in the hip joints
• possibility of cooperation on the part of the child (compliance with instructions),
• written consent of the child's parents or guardians to participate in the research.

Exclusion Criteria

• a child's height below 150 cm,
• a period of less than 6 months from the administration of botulinum toxin and an operation performed within the lower limbs within the last 2 years,
• dislocation or subluxation of the hip joints,
• contractures in the knee joints above 20 degrees,
• significant foot deformities,
• lack of cooperation on the part of the child,
• advanced osteoporosis making it impossible to stand up or be able to cause fractures during walking or standing training,
• active drug-resistant epilepsy,
• open skin lesions around the torso and / or lower limbs,
• cardiological contraindications for walking training,
• no consent for the child's participation in the project.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
three-dimensional gait analysis with system BTS Smart[the assessment will be performed before and after 6 weeks of therapy (primary endpoint) and after 6 months from the end of therapy]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath